Riskpilot← Back to searchSign inGet full accessHelena Käll Fysioterapi AB
ABActiveOrg 5569752032Kemistvägen 1Physiotherapy activities · NACE 8695Est. 20141 employees
Revenue 2025
SEK 1,5M
+16% vs 2024
EBITDA margin
11.3%
+7% vs 2024
Equity ratio
60.5%
Financial strength
Net profit 2025
SEK 129K
+27% vs 2024
| Revenue | SEK 1,5M | +16% |
| EBITDA | SEK 164K | +7% |
| Net profit | SEK 129K | +27% |
| Total assets | SEK 298K | +23% |
| Equity | SEK 180K | +19% |
| Employees | 1 | — |
Legal name
Helena Käll Fysioterapi AB
Org number
5569752032
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
23 juni 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva sjukgymnastik och fysioterapi på rehabklinik samt på fältet. Bolaget kommer att bedriva utbildningsverksamhet och kurser inom området fysioterapi och träning. Bolaget kommer att bedriva konsultverksamhet inom området och därmed förenlig verksamhet.
Address
Kemistvägen 1
Email
helena.kall@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 227 | 1 106 | 150 | 1 256 | 1 456 |
| Staff expenses | — | — | −39 | −855 | −880 |
| EBITDA | 188 | 107 | −20 | 153 | 164 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 188 | 107 | −20 | 153 | 164 |
| Net financials | — | — | 0 | 1 | 0 |
| Profit before tax | 188 | 107 | 6 | 130 | 164 |
| Tax | −40 | −23 | −3 | −29 | −35 |
| Net profit | 148 | 84 | 4 | 101 | 129 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 351 | 243 | 106 | 242 | 298 |
| Equity | 200 | 134 | 58 | 151 | 180 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 126 | 83 | 48 | 67 | 94 |
| Total debt | 126 | 83 | 48 | 67 | 94 |
EBITDA margin
11.3%
This company
15.8%
Market median
-28% vs market
20212025
Equity ratio
60.5%
This company
38.2%
Market median
+58% vs market
20212025
Return on equity
71.6%
This company
18.4%
Market median
+289% vs market
20212025
Net profit margin
8.9%
This company
8.1%
Market median
+10% vs market
20212025
Asset turnover
4.89×
This company
1.12×
Market median
+337% vs market
20212025
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Helena Käll Fysioterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Elisabeth Käll | Deputy Board Member | 0 companies |
| Helena Maria Käll Juhlin | Board of Directors | 0 companies |